David Tanzer, MD

Articles by David Tanzer, MD

David Tanzer, MD, CMO of Lexitas reflects on Retina World Congress

May 29th 2025

Lexitas Pharma Services' CMO discusses groundbreaking ophthalmology conference, emphasizing innovative clinical trials, emerging treatments for eye diseases, and the potential for transformative patient care strategies.

Latest Updated Articles

David Tanzer, MD, CMO of Lexitas reflects on Retina World Congress
Published: May 29th 2025 | Updated:

David Tanzer, MD

Articles by David Tanzer, MD

David Tanzer, MD, CMO of Lexitas reflects on Retina World Congress

Latest Updated Articles

Trending on Modern Retina

AAO 2025: Ashkan Abbey on the outcomes of EYP-1901 for AMD and DME

Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program

Leadership in action during the 2025 AAO named lectures

Empowerment through education: Q&A with Inder Paul Singh, MD